Morgan Stanley Maintains Overweight on Lam Research, Raises Price Target to $385

Benzinga Newsdesk www.benzinga.com Positive 80.6%

Neg 0% Neu 0% Pos 80.6%

Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and raises the price target from $367 to $385.